Total number of publications: 21
2022
-
A Helquat-like Compound as a Potent Inhibitor of Flaviviral and Coronaviral Polymerases
Molecules, year: 2022, volume: 27, edition: 6, DOI
-
Diphyllin Shows a Broad-Spectrum Antiviral Activity against Multiple Medically Important Enveloped RNA and DNA Viruses
Viruses, year: 2022, volume: 14, edition: 2, DOI
-
Guanine quadruplexes in the RNA genome of the tick-borne encephalitis virus: a new antiviral target
Year: 2022, type: Appeared in Conference without Proceedings
-
Guanine quadruplexes in the RNA genome of the tick-borne encephalitis virus: their role as a new antiviral target and in virus biology
Nucleic Acids Research, year: 2022, volume: 50, edition: 8, DOI
-
Monoclonal antibodies targeting two immunodominant epitopes on the Spike protein neutralize emerging SARS-CoV-2 variants of concern
EBioMedicine, year: 2022, volume: 76, edition: February, DOI
-
Porphyrins as potent inhibitors of the entry process of tick-borne encephalitis virus
Year: 2022, type: Conference abstract
-
Serum and cerebrospinal fluid phosphorylated neurofilament heavy subunit as a marker of neuroaxonal damage in tick-borne encephalitis.
Journal of General Virology, year: 2022, volume: 103, edition: 5, DOI
2021
-
Efektivita časné léčby COVID-19 kombinující remdesivir a rekonvalescentní plazmu s vysokým titrem u hematologických pacientů.
Year: 2021, type: Conference abstract
-
Porphyrins and metalloporphyrins as potent inhibitors of the entry process of tick-borne encephalitis virus
Year: 2021, type: Conference abstract
2020
-
FDA-Approved Drugs Efavirenz, Tipranavir, and Dasabuvir Inhibit Replication of Multiple Flaviviruses in Vero Cells
Microorganisms, year: 2020, volume: 8, edition: 4, DOI